Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development
- 18 February 2016
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 29 (3), 354-366
- https://doi.org/10.1016/j.ccell.2016.01.013
Abstract
No abstract availableKeywords
Funding Information
- ERC Advanced Investigator (ERC-2011-AdG294464)
- AICR (09-0586)
- European Union
- Greek national funds
This publication has 37 references indexed in Scilit:
- Targeting Epigenetic Readers in CancerNew England Journal of Medicine, 2012
- SMYD3 Promotes Cancer Invasion by Epigenetic Upregulation of the Metalloproteinase MMP-9Cancer Research, 2012
- Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3PLOS ONE, 2011
- Aberrations of EZH2 in CancerClinical Cancer Research, 2011
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetNature, 2011
- OPERating ON Chromatin, a Colorful Language where Context MattersJournal of Molecular Biology, 2011
- Nucleosome-Interacting Proteins Regulated by DNA and Histone MethylationCell, 2010
- Epithelial-mesenchymal transitions and hepatocarcinogenesisJCI Insight, 2010
- Enhanced SMYD3 expression is essential for the growth of breast cancer cellsCancer Science, 2006
- SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cellsNature, 2004